SYMPOSIUM PROGRAM
Three types of reports were presented at the Symposium:
Plenary/Keynote lectures - 20 minutes per talk + 10 minutes for questions, answers, and discussions.
Oral presentations - 15 minutes per talk + 5 minutes for questions, answers, and discussions.
Young Scientists flash presentations - 5 minutes per talk + 5 minutes for questions, answers, and discussions.
All reports were presented in English.
PDF version of the Symposium program.
Clicking on the name, title or play icon of the speaker, you can get acquainted with a biosketch, presentation and appearance.
Scheduled time - Moscow (UTC+3).
Wednesday May 25, 2022 |
|
Chairpersons: Kunal Roy, Timur Madzhidov |
|
Plenary lectures | |
10:00 |
MOLECULAR DYNAMICS STUDIES ON THE INTERACTIONS BETWEEN SARS-COV-2 SPIKE PROTEIN AND HACE2 OR MABS |
10:30 | |
Oral presentations | |
11:00 |
SARS-COV-2 MAIN PROTEASE INHIBITION WITH CARMOFUR A COMPUTATIONAL STUDY |
11:20 | |
11:40 | |
Keynote lectures | |
12:00 | |
12:30 |
HOW DO ENZYMES RECOGNIZE SUBSTRATES AND INHIBITORS: STRUCTURAL AND ELECTRON DENSITY ASPECTS |
Oral presentations | |
13:00 | |
13:20 |
ACTIVITY PREDICTION OF SARS-COV-2 MPRO INHIBITORS BASED ON ENSEMBLE DOCKING AND MACHINE LEARNING |
13:40 |
PHF10 THE SUBUNIT OF PBAF CHROMATIN REMODELING COMPLEX STRUCTURE AND FUNCTION PREDICTIONS |
lunch break 14:00-16:00 |
|
Chairpersons: Pavel Polishchuk, Vladimir Palyulin |
|
Young Scientists flash presentations | |
16:00 |
Dessiree Allyssa Tina (Play) Polytechnic University of the Philippines, Philippines |
16:10 |
Hadiatullah Hadiatullah (Play) Tianjin University, China |
16:20 |
COMPUTATIONAL APPROACH FOR IMPROVING OF KNOWN PERSPECTIVE SARS-COV-2 MPRO INHIBITORS Anatoliy Bulygin (Play) Institute of Chemical Biology and Fundamental Medicine; Novosibirsk State University, Russia |
16:30 |
MULTI-TARGET APPROACH ON LEISHMANIA DONOVANI AND FINDING OUT POTENT INHIBITORS FOR ESSENTIAL ENZYMES Debanjan Saha (Play) Tezpur University, India |
16:40 |
Alexandra Sadovskaya (Play) St. Petersburg State University, Russia |
16:50 |
Mohammed Efendi (Play) Gaziantep University, Turkey |
17:00 |
DIMERIC STATES OF TRANSMEMBRANE SEGMENTS OF THE DDR1 RECEPTOR PREDICTED BY ATOMISTIC MODELING Egor Kozlov (Play) Moscow Institute of Physics and Technology (National Research University), Russia |
17:10 |
Arkaprava Banerjee (Play) Jadavpur University, India |
17:20 |
INFORMATION EXTRACTION FROM TEXTS ANTIVIRAL AGENTS ACTIVE AGAINST VIRUS OR HOST PROTEINS Nadezhda Biziukova (Play) Institute of Biomedical Chemistry, Russia |
17:30 |
STRUCTURAL OPTIMIZATION OF TUBULIN INHIBITORS Aleksandra Ivanova (Play) Institute of Molecular and Translation Medicine; Palacky University in Olomouc; University Hospital in Olomouc, Czech Republic |
17:40 |
THE CONSENSUS ENSEMBLE NEURAL NETWORK MULTITARGET MODEL OF ANXIOLYTIC ACTIVITY Maksim Perfilev (Play) Volgograd State Medical University; Research Center for Innovative Medicines, Russia |
17:50 |
MOLECULAR DYNAMIC PHARMACOPHORE AND ITS APPLICATION IN DESIGNING NOVEL MARK4 INHIBITORS Alina Kutlushina (Play) Institute of Molecular and Translation Medicine, Czech Republic |
18:00 |
Ivan Kuznetsov (Play) Moscow University of Finance and Law, Russia |
18:10 |
TOWARDS THE DE NOVO DESIGN OF HIV-1 PROTEASE INHIBITORS BASED ON NATURAL PRODUCTS Ana Luisa Chavez-Hernandez (Play) National Autonomous University of Mexico, Mexico |
18:20 |
EXPLORING THE SCORING FUNCTION SPACE FOR STRUCTURE-BASED DRUG DESIGN Gabriela Bitencourt-Ferreira (Play) Pontifical Catholic University of Rio Grande do Sul, Brazil |
18:30 |
Luis Heriberto Vazquez Mendoza (Play) Escuela Superior de Medicina del Instituto Politécnico Nacional, Mexico |
18:40 |
Alessandra Latorre (Play) Universidad Nacional Mayor de San Marcos, Peru |
18:50 |
CONSENSUS VIRTUAL SCREENING OF NATURAL PRODUCT DERIVATIVES AGAINST TUBULIN Edgar López-López (Play) Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional; National Autonomous University of Mexico, Mexico |